Showing 5281-5290 of 6036 results for "".
- Trump Administration Pushes for Health Care Facilities to Reopenhttps://modernod.com/news/trump-administration-pushes-for-health-care-facilities-to-reopen/2477892/Healthcare facilities in states that have seen enough of a decline in COVID-19 cases to reach the Phase II criteria for reopening their economies should begin offering nonemergent, non-COVID-19 care, the Trump administration said Monday, according to a FierceHealthcare
- Market Scope: Premium IOL Volume Faces Challenges in Rebounding Post-COVIDhttps://modernod.com/news/market-scope-premium-iol-volume-faces-challenges-in-rebounding-post-covid/2477871/Results from Part 1 of Market Scope’s “COVID-19 US Practice Impact Survey” reveal that nearly 41 percent of surgeons expect a decrease in premium IOL conversion once COVID-19 subsides. These surgeons expect an average decrease of 34 percent, and most respondents believe that financial
- HHS Requiring Labs to Report Patients’ Race, Ethnicity With COVID-19 Tests in Effort to Combat Disparitieshttps://modernod.com/news/hhs-requiring-labs-to-report-patients-race-ethnicity-with-covid-19-tests-in-effort-to-combat-disparities/2477867/Following outcries from lawmakers and the public about the lack of demographic data for COVID-19 testing, the Trump administration is now requiring laboratories to collect demographic data like race, ethnicity, and sex when reporting test results, according to a FierceHealthcare
- The Lancet Withdraws Major Hydroxychloroquine Studyhttps://modernod.com/news/the-lancet-withdraws-controversial-hydroxychloroquine-study/2477866/A major study in the Lancet that suggested hydroxychloroquine was associated with higher rates of ventricular arrhythmia and death in COVID-19 patients has been retracted. The multinational registry analysis, published in the Lancet on May 22, included nearly 15,000 peopl
- SightGlass Vision Granted CE Mark for Eyeglasses That Slow Myopia Progression in Childrenhttps://modernod.com/news/sightglass-vision-granted-ce-mark-for-novel-eyeglasses-that-slow-myopia-progression-in-children/2477859/SightGlass Vision announced it has achieved CE Mark approval for its first product – novel eyeglasses designed to slow the progression of myopia in children. The approval allows the SightGlass Vision to commercialize its suite of Diffusion Optics Technology (DOT) products across the EU,
- Lasik Vision Institute, TLC Laser Eye Center Operator Files for Bankruptcyhttps://modernod.com/news/lasik-vision-institute-tlc-laser-eye-center-operator-files-for-bankruptcy/2477856/Vision Group Holdings, the management company behind two leading LASIK surgery brands, filed for bankruptcy protection and launched a sale process aimed at placing the business into new hands as its surgical centers reopen, according to a Wall Street Journal
- Re-vana Therapeutics Raises $3.25 Million in Pre-Series A Financinghttps://modernod.com/news/re-vana-therapeutics-raises-3-25-million-in-pre-series-a-financing/2477857/Re-Vana Therapeutics, a privately-held specialty therapeutic and drug delivery company developing sustained-release therapeutics for significant sight-threatening ocular diseases, announced that it has closed $3.25 mi
- Lilly Begins World’s First Human Study of Antibody to Treat COVID-19https://modernod.com/news/lilly-begins-worlds-first-human-study-of-antibody-to-treat-covid-19/2477853/Eli Lilly said that the first patients have been dosed in a phase 1 trial investigating the experimental antibody LY-CoV555 for the treatment of COVID-19. The company, which is developing the drug with partner AbCellera, noted that the move marks the world’s first study of a potential antib
- Ocugen to Discontinue Phase 3 oGVHD Trialhttps://modernod.com/news/ocugen-to-discontinue-phase-3-ogvhd-trial/2477849/Ocugen announced the decision to discontinue the phase 3 trial of OCU300 for ocular Graft vs. Host Disease (oGVHD). The decision to stop the trial is based on results of a pre-planned interim sample size analysis conducted by an independent data monitoring committee, which indicated
- Johnson & Johnson Vision Appoints Erin McEachren as Regional Vice President, Surgical, EMEAhttps://modernod.com/news/johnson-johnson-vision-appoints-erin-mceachren-as-regional-vice-president-surgical-emea/2477847/Johnson & Johnson Vision has appointed Erin McEachren to the position of Regional Vice President for Johnson & Johnson Surgical Vision, EMEA. In this role, Ms. McEachren will lead Johnson & Johnson’s high-performance surgical vision team to address the unmet needs of patients and eye